Pancreatic Cancer Research

ResearcherAichi Medical UniversityNo recent work listed

Kenji Kasai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6566-9483; OpenAlex author ID A5046171790. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
2
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper

Papers 5

  1. GLI1, a master regulator of the hallmark of pancreatic cancer. Co-author DOI 10.1111/pin.12476↗
  2. Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2. Last author DOI 10.18632/oncotarget.4960↗
  3. GLI1 interferes with the DNA mismatch repair system in pancreatic cancer through BHLHE41-mediated suppression of MLH1. Last author DOI 10.1158/0008-5472.can-13-2008↗
  4. GLI1 modulates EMT in pancreatic cancer--letter. First author DOI 10.1158/0008-5472.can-12-0379↗
  5. GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin. First author DOI 10.1038/onc.2010.459↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shingo Inaguma · 4 shared papers, 2011–2015 · strength 0.19
  2. Hiroshi Ikeda · 4 shared papers, 2011–2015 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.